In the last decades, survival rate of hematological malignancies has been significantly improved and sparing reproductive potential after treatment has become one of the goals in both male and female patients. A comprehensive consultation with reproductive specialists before the onset of any kind of cancer treatment procedure is an essential issue which would increase the likelihood of parenting in survivors. In this context, cryopreservation of oocyte, embryo or ovarian tissue in reproductive aged women and sperm or testicular tissue cryopreservation in adult male are feasible approaches that must be considered before gonadotoxic therapy. Notably, all options should be regarded as experimental during pre-pubertal period. Herein, we aim to review the available literature with regard to safety, efficacy of fertility preservation methods and the pregnancy outcomes in patients with hematological malignancies.
CITATION STYLE
Ozdemir, Z. N., & Bozdag, S. C. (2020). Hematological malignancies and fertility. In Advances in Experimental Medicine and Biology (Vol. 1288, pp. 103–115). Springer. https://doi.org/10.1007/5584_2020_490
Mendeley helps you to discover research relevant for your work.